US Digital Therapeutics Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : January 2022
  • Region: North America
  • Country: US
  • Report ID : 5020

  • Format: PPT, PDF

US Digital Therapeutics Market Analysis: Segmented by Application, end use – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5020 Categories: ,

Report Description of the US Digital Therapeutics Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for US Digital Therapeutics Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the US Digital Therapeutics Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

US Digital Therapeutics Market Analysis Executive Summary

The U.S. digital therapeutics market size was valued at USD 1.05 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 22.2% from 2020 to 2027. Digital Therapeutics (DTx) deliver a wide range of services, encouraging users to adopt healthy habits and efficiently track and manage their health conditions which is increasing the demand. Continuously changing digital landscape and outbreak COVID 19 pandemic has led to an increase in the adoption. Furthermore, increased use of the internet and smartphones is one of the major factors driving the market growth.

Market Size and Key Findings

The US Digital Therapeutics Market Analysis size stood at around USD 1.34 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 22.2% during the forecast period.

The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period. Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics.

Market Dynamics

Market Growth Drivers Analysis

Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders. They are utilized alone or mix with medications, devices or other therapies to optimize patient care and health outcomes. Rising remote access to therapies that are clinically tested as safe and effective is one of the properties of digital therapeutics (DTx) during the treatment.

The technological advancement which the companies make in order to grow their product line and gain profits are one of the drivers for the growth of the digital therapeutic (DTx) market. The collaboration between the companies will help in the growth of the market and will act as an opportunity for the digital therapeutic (DTx) market.

The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the digital therapeutic (DTx) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Market Restraints

The privacy concerns related to digital therapeutic (DTx) apps may act as a restraint for the growth of the digital therapeutic (DTx) market. The quality of digital therapeutic (DTx) is to be maintained in order to provide better treatment and proper care for the customers, hence, this needs to be done correctly, therefore this would act as challenge for the digital therapeutic (DTx) market because many a times the need is not met.

COVID-19 impact on “US Digital Therapeutics Market Analysis” 

The demand has been increased after the nationwide lockdown due to covid-19. According to the KFF tracking poll in March 2020, around 47% of Americans staying at home have reported negative mental health effects. Out of them, over 21% have reported a major negative impact on their mental health. The FDA has released new guidelines for the computerized behavioral therapy and other DTx solutions during this public health emergency which is expected to fuel the growth.

Competitive Landscape

Key Players

The digital therapeutic (DTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to digital therapeutic (DTx) market.

The major players covered in the North America digital therapeutic (DTx) market report are Fitbit, Inc., Livongo, ResMed, Omada Health, Inc., Noom, Inc., Happify, Inc., Welldoc, Inc., SAMSUNG, ATENTIV, MANGO HEALTH, CogniFit, Kaia Health, Mindstrong Health, Smartpatient gmbh, Ayogo Health Inc., Ginger, Better Therapeutics, Inc., 2Morrow Inc., CANARY HEALTH, Click Therapeutics, Inc., Cognoa, Pear Therapeutics, Inc., Voluntis, Akili Interactive Labs, Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Products in Pipeline

In August 2019, ATENTIV had agreed with Children’s Specialized Hospital’s Center. The collaboration tie-up between the two comprises of co-development of a unified behavioral and basic treatment operating system that utilizes the best clinical practices for the conveyance of ATENTIV mynd by primary care clinicians. This collaboration tie-up would increase the company’s brand value and market value of the product.

Notable Recent Deals

  • The players are taking strategic initiatives such as product launch, merger and acquisitions, pending FDA approval in order to gain more market share. For instance, in March 2020 USFDA approved Somryst by Pear Therapeutics for chronic insomnia, which includes algorithm-driven sleep restriction, recommendations, and consolidation. In November 2019, Blue Cross Blue Shield of Minnesota announced to provide reimbursement for Omada’s diabetes prevention program to its self-insured payers. In January 2019, Proteus Digital health launched digital oncology medicines to improve the outcomes and treatments of cancer patients, enhancing the company’s market growth.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

North America region holds the majority of the share in the digital therapeutic (DTx) market and is expected to witness the CAGR during the forecast period due to increasing number of cases in diabetes. The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) products

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

1. Report Description of the US Digital Therapeutics Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. US Digital Therapeutics Market Analysis Executive Summary
2.1 US Digital Therapeutics Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of US Digital Therapeutics Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Rise in Prevalence of Chronic Diseases
3.1.2 Increase in Awareness by Government agencies
3.1.3 Technological Advancement in Healthcare
3.1.4 Increased number of people using smartphones
3.1.5 Improved Quality of Life
3.2 Market Restraints Analysis
3.2.1 Patient Information Privacy Policies
3.2.2 Digital Payment associated with Digital Therapeutics
3.2.3 Under developing countries lacking smartphones and internet facilities.
3.3 Covid-19 Market Impact Analysis
4. US Digital Therapeutics Market Segmentation
4.1 By Application:
4.1.1 Diabetes
4.1.2 Obesity
4.1.3 CVD
4.1.4 Respiratory Diseases
4.1.5 Smoking Cessation
4.1.6 CNS Disease
4.1.7 Others
4.2 By End-use:
4.2.1 Patients
4.2.2 Providers
4.2.3 Payers
4.2.4 Employers
4.2.5 Others
5. Digital Therapeutics Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Apheresis Market
6.4 Notable recent deals in Apheresis Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Proteus Digital Health, Inc. Company overview
Product & Services, Strategies & Financials
7.2 Omada Health, Inc. Company overview
Product & Services, Strategies & Financials
7.3 Livongo Health, Inc. Company overview
Product & Services, Strategies & Financials
7.4 2Morrow, Inc. Company overview
Product & Services, Strategies & Financials
7.5 Propeller Health Company overview
Product & Services, Strategies & Financials
7.6 Fitbit, Inc. Company overview
Product & Services, Strategies & Financials
7.7 Canary Health Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Apheresis market
9.2 Future Opportunities
10. Strategic Recommendations

US Digital Therapeutics Market Analysis Segmentation

By Application:

Diabetes dominated the application segment with a revenue share of over 24% in 2019. Diabetes prevalence is growing rapidly and is linked to blindness, heart attack, kidney failure, stroke, and gangrene in severe cases. Digital therapeutics are being used for the management & prevention of diseases by helping patients change their behavior through constant monitoring, improving their health in the long run. On the basis of application, the U.S. digital therapeutics market is segmented into diabetes, obesity, CVD, respiratory diseases, smoking cessation, CNS diseases, and others.

CNS disease segment is expected to showcase the fastest CAGR over the forecast period owing to the increasing incidence of neurological diseases in the country. Alzheimer’s disease, expressive aphasia, degenerative diseases, Huntington’s disease, multiple sclerosis, and Parkinson’s disease are some of the most common neurological diseases that affect a growing proportion of the U.S. Several digital therapeutics companies have been catering to the specific needs of Central Nervous System (CNS) disease patients to reduce anxiety and keep track of daily activities.

By End-use:

Patients segment dominated the end-use segment with a share of around 33% in 2019. The increased adoption of these tools can be attributed to their added benefits, one of which is effective health management at an affordable cost. In addition, the presence of advanced healthcare IT solutions and supportive government programs in the country are factors expected to further boost the adoption of digital therapeutics by patients. On the basis of end-use, the market is segmented into patients, providers, payers, employers, and others.

Employer segment is expected to be the fastest-growing sub-segment over the forecast period. Employers are focusing on the management of employee healthcare costs, which is expected to drive segment growth. Moreover, growing awareness through employee healthcare programs is expected to propel the adoption of digital therapeutics for maintaining employee wellbeing. The availability of various mHealth apps, such as Vida Health, used by payers, providers, and employers to monitor chronic conditions such as prediabetes, obesity, hypertension, and mental health issues, is another factor expected to propel market growth.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements